Lexaria Bioscience's total assets for Q3 2026 were $4.78M, a decrease of -26.30% from the previous quarter. LEXX total liabilities were $437.09K for the fiscal quarter, a 57.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.